Items of recent pandemic news: Minnesota’s oddly bright prospects; Israel offers a fourth shot; the end of the pandemic as a social phenomenon; and what happens when Omicron hits a population with pre-existing immunity. Plus a frippery. Quotes of the … Continue reading →
The FDA has issued an emergency use authorization for Merck’s Molnupiravir, an oral antiviral to prevent mild or moderate Covid-19 from progressing to more serious disease, for those aged 18+ for whom other treatment options are not accessible / appropriate. … Continue reading →
The Food and Drug Administration has issued an emergency use authorization for Pfizer’s Paxlovid (nirmatrelvir and ritonavir), an oral antiviral to prevent mild or moderate Covid-19 from progressing to more serious disease. Supplies will be severely limited for now. Paxlovid … Continue reading →
Items of recent pandemic news: Novavax notches some wins; J&J’s vaccine is deprecated; vaccines for young kids will have to wait; the US government is stockpiling antibodies; the implications of Omicron’s (possibly) faster incubation; and more. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Those who pay zero attention to the pandemic; the evolutionary weirdness of Omicron; the class-based roots of vaccine avoidance; boosters authorized for people aged 16-17; and Paxlovid’s continuing promise. Plus a frippery. Paxlovid holds up … Continue reading →
Items of recent pandemic news: A common cold coronavirus may have mixed into Omicron; AstraZeneca’s long-lasting injectable antibody gets authorized; SARS-CoV-2 can infect fat cells; what we tentatively know about Omicron; and much more. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Simulating an aerosolized virus particle with 1.3 billion atoms via a supercomputer; the first monoclonal antibody treatment authorized for young children; Omicron may be breaking through natural immunity; and molnupiravir’s tepid affirmation. Plus a frippery. … Continue reading →
Items of recent pandemic news: Survivors of severe Covid have double the odds of dying, from all causes, within a year; Minnesota’s fading Delta surge; where the Omicron variant may have come from; and more. Plus a frippery. Omicron update … Continue reading →
Items of recent pandemic news: Quantifying the immunity advantage over natural infection that you get from boosting; nucleotide sequences released for the vaccines; an update on Omicron; and what we should do about it right now. Plus a frippery. Quotes … Continue reading →
The new worrisome variant we wrote about yesterday, now named Omicron, is roiling the world today. B.1.1.529 was first identified in Botswana, in southern Africa, based on four cases in fully vaccinated people. Another six cases were soon spotted in … Continue reading →
This could be something. South African scientists grew concerned that a new SARS-CoV-2 variant is making inroads against Delta in one province of the country. Today (Thursday Nov. 25) they briefed public health authorities and others in government, up to … Continue reading →
Items of recent pandemic news: CureVac’s second-generation vaccine does as well as Pfizer / BioNTech’s in a pre-clinical trial; the brain may participate directly in immune memory; and approval for boosters for all US adults. Plus a frippery. Boosters for … Continue reading →
Items of recent pandemic news: The Great Resignation among healthcare workers; the CDC may stop talking about herd immunity; the sobering prevalance of long Covid; the fifth pandemic wave crashing over Europe; and considerations for oral antivirals. Plus a frippery. … Continue reading →
Items of recent pandemic news: the US government buys more of Merck’s molnupiravir; a possible shortage of syringes looms next year; how Covid-19 affects the heart; and a pause in the administration’s vaccine mandate for companies. Plus a frippery. Biden’s … Continue reading →
Items of recent pandemic news: Deer may provide a SARS-CoV-2 reservior; OSHA promulgates rules implementing the Biden administration’s workplace vaccine mandate; and a strong showing for Pfizer’s oral medication against SARS-CoV-2. Plus a frippery. Pfizer’s anti-Covid pill shows strong results … Continue reading →
